https://www.selleckchem.com/pr....oducts/l-histidine-m
, and as such it is worthy of clinical promotion. The purpose of this study was to identify the optimal treatment plan for hospitalized patients with community-acquired pneumonia (CAP) by evaluating related studies on combination therapies of β-lactams/macrolides (BLM) and β-lactams/fluoroquinolones (BLFQ) in the treatment of CAP. A meta-analysis was performed on studies with mortality rates as the main result using PubMed, Scopus, Cochrane, and other journal databases. The literature was evaluated usin
Aimer
Commentaire
Partagez
